Clinical Trials Browser

NIH × Neoplasms × ropidoxuridine × Clear all

NCT01240577 2018-10-18

An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas

Phase 1 Completed

Lymphoma, Neoplasms